The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

Meticillin     (2R,5R,6S)-6-[(2,6- dimethoxyphenyl)carbony...

Synonyms: Dimocillin, Metacillin, Meticilina, Methycillin, Meticillina, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of methicillin

 

Psychiatry related information on methicillin

 

High impact information on methicillin

 

Chemical compound and disease context of methicillin

  • Gentamicin and antiseptic resistance in epidemic methicillin-resistant Staphylococcus aureus [15].
  • Because ramoplanin is structurally less complex than glycopeptide antibiotics such as vancomycin, peptidomimetic chemotherapeutics derived from this recognition sequence may find future use as antibiotics against vancomycin-resistant Enterococcus faecium, methicillin-resistant Staphylococcus aureus, and related pathogens [16].
  • An analogue of isoleucyl-adenylate (Ile-AMS) potently inhibits the isoleucyl-tRNA synthetases (IleRSs) from the three primary kingdoms, whereas the antibiotic mupirocin inhibits only the eubacterial and archaeal IleRSs, but not the eukaryotic enzymes, and therefore is clinically used against methicillin-resistant Staphylococcus aureus [17].
  • Laboratory mutants of Staphylococcus aureus strain ATCC 8325 (27S) selected for increased minimal inhibitory concentration (MIC) values to methicillin and cefotaxime showed increased rates of cell wall turnover and detergent-induced autolysis in virtual parallel with the increasing MIC for the antibiotic [18].
  • All seven patients patronized a local "shooting gallery" where paraphernalia were provided and drugs were often administered by a "street doctor." All isolates were phage type 29/77/83A/84/85 and demonstrated resistance only to methicillin, oxacillin, and penicillin [19].
 

Biological context of methicillin

 

Anatomical context of methicillin

 

Associations of methicillin with other chemical compounds

 

Gene context of methicillin

 

Analytical, diagnostic and therapeutic context of methicillin

References

  1. Community-acquired methicillin-resistant Staphylococcus aureus infection. Berman, D.S., Eisner, W., Kreiswirth, B. N. Engl. J. Med. (1993) [Pubmed]
  2. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group. Smith, T.L., Pearson, M.L., Wilcox, K.R., Cruz, C., Lancaster, M.V., Robinson-Dunn, B., Tenover, F.C., Zervos, M.J., Band, J.D., White, E., Jarvis, W.R. N. Engl. J. Med. (1999) [Pubmed]
  3. Letter: Interstitial nephritis after methicillin. Mayaud, C., Kanfer, A., Kourilsky, O., Sraer, J.D. N. Engl. J. Med. (1975) [Pubmed]
  4. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. Vincent, J.L., Bihari, D.J., Suter, P.M., Bruining, H.A., White, J., Nicolas-Chanoin, M.H., Wolff, M., Spencer, R.C., Hemmer, M. JAMA (1995) [Pubmed]
  5. Changes in nongonococcal septic arthritis: drug abuse and methicillin-resistant Staphylococcus aureus. Ang-Fonte, G.Z., Rozboril, M.B., Thompson, G.R. Arthritis Rheum. (1985) [Pubmed]
  6. Nephropathy associated with methicillin therapy. Prevalence and determinants in patients with staphylococcal bacteremia. Nolan, C.M., Abernathy, R.S. Arch. Intern. Med. (1977) [Pubmed]
  7. Community-acquired methicillin-resistant Staphylococcus aureus in institutionalized adults with developmental disabilities. Borer, A., Gilad, J., Yagupsky, P., Peled, N., Porat, N., Trefler, R., Shprecher-Levy, H., Riesenberg, K., Shipman, M., Schlaeffer, F. Emerging Infect. Dis. (2002) [Pubmed]
  8. Degradation of penicillin-binding protein 2' in methicillin-resistant Staphylococcus aureus. Sumita, Y., Fukasawa, M., Mitsuhashi, S., Inoue, M. Chemotherapy. (1995) [Pubmed]
  9. Methicillin-resistant Staphylococcus aureus infections following esophageal surgery in patients with impaired defense mechanisms. Saito, T., Kinoshita, T., Shigemitsu, Y., Katsuta, T., Shimoda, K., Kobayashi, M. Surgery today. (1993) [Pubmed]
  10. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection. Sieradzki, K., Roberts, R.B., Haber, S.W., Tomasz, A. N. Engl. J. Med. (1999) [Pubmed]
  11. Emergence of multiply resistant pneumococci. Jacobs, M.R., Koornhof, H.J., Robins-Browne, R.M., Stevenson, C.M., Vermaak, Z.A., Freiman, I., Miller, G.B., Witcomb, M.A., Isaäcson, M., Ward, J.I., Austrian, R. N. Engl. J. Med. (1978) [Pubmed]
  12. Evidence for a clonal origin of methicillin resistance in Staphylococcus aureus. Kreiswirth, B., Kornblum, J., Arbeit, R.D., Eisner, W., Maslow, J.N., McGeer, A., Low, D.E., Novick, R.P. Science (1993) [Pubmed]
  13. Three different neutrophil subsets exhibited in mice with different susceptibilities to infection by methicillin-resistant Staphylococcus aureus. Tsuda, Y., Takahashi, H., Kobayashi, M., Hanafusa, T., Herndon, D.N., Suzuki, F. Immunity (2004) [Pubmed]
  14. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. Herold, B.C., Immergluck, L.C., Maranan, M.C., Lauderdale, D.S., Gaskin, R.E., Boyle-Vavra, S., Leitch, C.D., Daum, R.S. JAMA (1998) [Pubmed]
  15. Gentamicin and antiseptic resistance in epidemic methicillin-resistant Staphylococcus aureus. Gillespie, M.T., Lyon, B.R., Skurray, R.A. Lancet (1989) [Pubmed]
  16. Complexation of peptidoglycan intermediates by the lipoglycodepsipeptide antibiotic ramoplanin: minimal structural requirements for intermolecular complexation and fibril formation. Cudic, P., Kranz, J.K., Behenna, D.C., Kruger, R.G., Tadesse, H., Wand, A.J., Veklich, Y.I., Weisel, J.W., McCafferty, D.G. Proc. Natl. Acad. Sci. U.S.A. (2002) [Pubmed]
  17. Structural basis for the recognition of isoleucyl-adenylate and an antibiotic, mupirocin, by isoleucyl-tRNA synthetase. Nakama, T., Nureki, O., Yokoyama, S. J. Biol. Chem. (2001) [Pubmed]
  18. Structural characterization of an abnormally cross-linked muropeptide dimer that is accumulated in the peptidoglycan of methicillin- and cefotaxime-resistant mutants of Staphylococcus aureus. Boneca, I.G., Xu, N., Gage, D.A., de Jonge, B.L., Tomasz, A. J. Biol. Chem. (1997) [Pubmed]
  19. Methicillin-resistant Staphylococcus aureus bacteremia linked to intravenous drug abusers using a "shooting gallery". Craven, D.E., Rixinger, A.I., Goularte, T.A., McCabe, W.R. Am. J. Med. (1986) [Pubmed]
  20. Are the epidemiology and microbiology of methicillin-resistant Staphylococcus aureus changing? Boyce, J.M. JAMA (1998) [Pubmed]
  21. Genome and virulence determinants of high virulence community-acquired MRSA. Baba, T., Takeuchi, F., Kuroda, M., Yuzawa, H., Aoki, K., Oguchi, A., Nagai, Y., Iwama, N., Asano, K., Naimi, T., Kuroda, H., Cui, L., Yamamoto, K., Hiramatsu, K. Lancet (2002) [Pubmed]
  22. World-wide antibiotic resistance in methicillin-resistant Staphylococcus aureus. Maple, P.A., Hamilton-Miller, J.M., Brumfitt, W. Lancet (1989) [Pubmed]
  23. In-vivo transfer of mecA DNA to Staphylococcus aureus [corrected]. Wielders, C.L., Vriens, M.R., Brisse, S., de Graaf-Miltenburg, L.A., Troelstra, A., Fleer, A., Schmitz, F.J., Verhoef, J., Fluit, A.C. Lancet (2001) [Pubmed]
  24. Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Kuroda, M., Ohta, T., Uchiyama, I., Baba, T., Yuzawa, H., Kobayashi, I., Cui, L., Oguchi, A., Aoki, K., Nagai, Y., Lian, J., Ito, T., Kanamori, M., Matsumaru, H., Maruyama, A., Murakami, H., Hosoyama, A., Mizutani-Ui, Y., Takahashi, N.K., Sawano, T., Inoue, R., Kaito, C., Sekimizu, K., Hirakawa, H., Kuhara, S., Goto, S., Yabuzaki, J., Kanehisa, M., Yamashita, A., Oshima, K., Furuya, K., Yoshino, C., Shiba, T., Hattori, M., Ogasawara, N., Hayashi, H., Hiramatsu, K. Lancet (2001) [Pubmed]
  25. Resistance to methicillin and other antibiotics in isolates of Staphylococcus aureus from blood and cerebrospinal fluid, England and Wales, 1989-95. Speller, D.C., Johnson, A.P., James, D., Marples, R.R., Charlett, A., George, R.C. Lancet (1997) [Pubmed]
  26. Selective decontamination of the digestive tract and methicillin-resistant Staphylococcus aureus. Kaufhold, A., Behrendt, W., Kräuss, T., van Saene, H. Lancet (1992) [Pubmed]
  27. Effectiveness of cloxacillin with and without gentamicin in short-term therapy for right-sided Staphylococcus aureus endocarditis. A randomized, controlled trial. Ribera, E., Gómez-Jimenez, J., Cortes, E., del Valle, O., Planes, A., Gonzalez-Alujas, T., Almirante, B., Ocaña, I., Pahissa, A. Ann. Intern. Med. (1996) [Pubmed]
  28. The essential Staphylococcus aureus gene fmhB is involved in the first step of peptidoglycan pentaglycine interpeptide formation. Rohrer, S., Ehlert, K., Tschierske, M., Labischinski, H., Berger-Bächi, B. Proc. Natl. Acad. Sci. U.S.A. (1999) [Pubmed]
  29. Intracellular methicillin selection of Listeria monocytogenes mutants unable to replicate in a macrophage cell line. Camilli, A., Paynton, C.R., Portnoy, D.A. Proc. Natl. Acad. Sci. U.S.A. (1989) [Pubmed]
  30. Methicillin-resistant Staphylococcus aureus: introduction and spread within a hospital. Peacock, J.E., Marsik, F.J., Wenzel, R.P. Ann. Intern. Med. (1980) [Pubmed]
  31. Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. Holden, M.T., Feil, E.J., Lindsay, J.A., Peacock, S.J., Day, N.P., Enright, M.C., Foster, T.J., Moore, C.E., Hurst, L., Atkin, R., Barron, A., Bason, N., Bentley, S.D., Chillingworth, C., Chillingworth, T., Churcher, C., Clark, L., Corton, C., Cronin, A., Doggett, J., Dowd, L., Feltwell, T., Hance, Z., Harris, B., Hauser, H., Holroyd, S., Jagels, K., James, K.D., Lennard, N., Line, A., Mayes, R., Moule, S., Mungall, K., Ormond, D., Quail, M.A., Rabbinowitsch, E., Rutherford, K., Sanders, M., Sharp, S., Simmonds, M., Stevens, K., Whitehead, S., Barrell, B.G., Spratt, B.G., Parkhill, J. Proc. Natl. Acad. Sci. U.S.A. (2004) [Pubmed]
  32. Defective platelet function following the administration of penicillin compounds. Brown, C.H., Bradshaw, M.J., Natelson, E.A., Alfrey, C.P., Williams, T.W. Blood (1976) [Pubmed]
  33. beta-lactamase from Streptomyces cacaoi. Purification and properties. Ogawara, H., Mantoku, A., Shimada, S. J. Biol. Chem. (1981) [Pubmed]
  34. Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Chambers, H.F. Clin. Microbiol. Rev. (1997) [Pubmed]
  35. Discrete steps in sensing of beta-lactam antibiotics by the BlaR1 protein of the methicillin-resistant Staphylococcus aureus bacterium. Thumanu, K., Cha, J., Fisher, J.F., Perrins, R., Mobashery, S., Wharton, C. Proc. Natl. Acad. Sci. U.S.A. (2006) [Pubmed]
  36. On the transcriptional regulation of methicillin resistance: MecI repressor in complex with its operator. García-Castellanos, R., Mallorquí-Fernández, G., Marrero, A., Potempa, J., Coll, M., Gomis-Rüth, F.X. J. Biol. Chem. (2004) [Pubmed]
  37. Rearrangements in the staphylococcal beta-lactamase-encoding plasmid, pIP1066, including a DNA inversion that generates two alternative transposons. Derbise, A., Dyke, K.G., el Solh, N. Mol. Microbiol. (1995) [Pubmed]
  38. blaI and blaR1 regulate beta-lactamase and PBP 2a production in methicillin-resistant Staphylococcus aureus. Hackbarth, C.J., Chambers, H.F. Antimicrob. Agents Chemother. (1993) [Pubmed]
  39. Tourniquets and nosocomial methicillin-resistant Staphylococcus aureus infections. Berman, D.S., Schaefler, S., Simberkoff, M.S., Rahal, J.J. N. Engl. J. Med. (1986) [Pubmed]
  40. Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit. Chaix, C., Durand-Zaleski, I., Alberti, C., Brun-Buisson, C. JAMA (1999) [Pubmed]
  41. Methicillin-resistant staphylococci 1965-75. Kayser, F.H. Lancet (1975) [Pubmed]
  42. Methicillin-resistant staphylococcal colonization and infection in a long-term care facility. Muder, R.R., Brennen, C., Wagener, M.M., Vickers, R.M., Rihs, J.D., Hancock, G.A., Yee, Y.C., Miller, J.M., Yu, V.L. Ann. Intern. Med. (1991) [Pubmed]
 
WikiGenes - Universities